891 results on '"Kushner, Robert F"'
Search Results
102. 83-OR: Influence of Baseline Characteristics on Weight Loss with Semaglutide 2.4 mg in Adults with Overweight/Obesity and Type 2 Diabetes (STEP 2)
103. 80-OR: Treatment with Once-Weekly Semaglutide 2.4 mg Improves Cardiometabolic Risk Factors in Adults with Overweight/Obesity and Type 2 Diabetes: STEP 2 Post-hoc Analysis
104. Once-weekly Subcutaneous Semaglutide 2.4 mg Reduces Body Weight in Adults with Overweight or Obesity Regardless of Baseline Characteristics (STEP 1)
105. Clinically-Relevant Weight Loss is Achieved Independently of Early Weight Loss Response to Once-Weekly Subcutaneous Semaglutide 2.4 MG (STEP 4)
106. Efficacy and Safety of Once-Weekly Subcutaneous Semaglutide 2.4 MG in Adults With Overweight or Obesity (STEP 1)
107. Impact of Semaglutide on Body Composition in Adults With Overweight or Obesity: Exploratory Analysis of the STEP 1 Study
108. A standard calculation methodology for human doubly labeled water studies
109. Electronic Tools to Assist with Identification and Counseling for Overweight Patients: a Randomized Controlled Trial
110. American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery Medical Guidelines for Clinical Practice for the Perioperative Nutritional, Metabolic, and Nonsurgical Support of the Bariatric Surgery Patient
111. Principles and nonpharmacologic management of obesity in adults
112. Assessment and Lifestyle Management of Patients With Obesity: Clinical Recommendations From Systematic Reviews
113. Inpatient obesity intervention with postdischarge telephone follow-up: A randomized trial
114. Roundtable Discussion: COVID-19 and Obesity—Implications and Integrative Management
115. Once-Weekly Semaglutide in Adults with Overweight or Obesity
116. Creating a lifestyle medicine center: from concept to clinical practice
117. Contributors
118. Surgery for Severe Obesity
119. Emergence of Pica (Ingestion of Non-food Substances) Accompanying Iron Deficiency Anemia after Gastric Bypass Surgery
120. Nutritional support of the obese patient
121. Long-term Complications of Bariatric Surgery—Reply
122. Screening and diagnosis
123. Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design
124. Risk assessment of the overweight and obese patient
125. Reemergence of pica following gastric bypass surgery for obesity: a new presentation of an old problem
126. Obesity and Therapeutic Approaches to Weight Loss
127. Using psycho‐behavioral phenotyping for overweight and obesity: Confirmation of the 6 factor questionnaire.
128. CONTRIBUTORS
129. OBESITY AND NUTRITION
130. Obesity management
131. Pharmacologic management of obesity
132. Obesity Medicine—The Time Has Come
133. Current Strategies of Critical Care Assessment and Therapy of the Obese Patient (Hypocaloric Feeding): What Are We Doing and What Do We Need to Do?
134. Diagnosing Obesity as a First Step to Weight Loss: An Observational Study
135. What COVID‐19 is Teaching Us About Counseling for Weight Management
136. Benefits and Risks of Bariatric Surgery in Adults
137. Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5
138. Clinical Practice Guidelines for the Perioperative Nutrition, Metabolic, and Nonsurgical Support of Patients Undergoing Bariatric Procedures – 2019 Update: Cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic and Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists
139. Weight History in Clinical Practice: The State of the Science and Future Directions
140. Tackling Obesity: Is Primary Care Up to the Challenge?
141. Dietary Therapy of Obesity
142. Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society
143. Partial Retraction
144. EXECUTIVE SUMMARY OF THE RECOMMENDATIONS OF THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, THE OBESITY SOCIETY, AND AMERICAN SOCIETY FOR METABOLIC & BARIATRIC SURGERY MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE PERIOPERATIVE NUTRITIONAL, METABOLIC, AND NONSURGICAL SUPPORT OF THE BARIATRIC SURGERY PATIENT
145. Long-term Outcome of Bariatric Surgery: An Interim Analysis
146. Low-Carbohydrate Diets, Con: The Mythical Phoenix or Credible Science?
147. Aspiration therapy for the treatment of obesity: 4-year results of a multicenter randomized controlled trial.
148. Putting an Obesity “Call to Action” Into Action
149. Relative dilution spaces of 2H- and 18O-labeled water in humans
150. National Coordinating Committee clinical indicators of nutrition care
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.